Standard
Harvard
Dunn, K, Hindley, A
, Wood, L, Sanneh, A, Barber, D
, Whitehead, A & Zain, Z 2013, '
Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy: a double-blind randomized control trial in 120 patients',
International Journal of Radiation Oncology - Biology - Physics, vol. 87, no. 2 Supplement, pp. S115.
https://doi.org/10.1016/j.ijrobp.2013.06.297
APA
Dunn, K., Hindley, A.
, Wood, L., Sanneh, A., Barber, D.
, Whitehead, A., & Zain, Z. (2013).
Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy: a double-blind randomized control trial in 120 patients.
International Journal of Radiation Oncology - Biology - Physics,
87(2 Supplement), S115.
https://doi.org/10.1016/j.ijrobp.2013.06.297
Vancouver
Author
Bibtex
@article{b5c45d3cbfea4e1898ef831bcee071e3,
title = "Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy: a double-blind randomized control trial in 120 patients",
abstract = "The most common acute side effect of patients receiving radiation therapy to the breast/chest wall is radiation induced dermatitis. Despite this, there is no accepted intervention to prevent or treat it. A previous study by Bostrom et al showed Mometasone Furoate (M) cream was superior to Diprobase (D) in a study of 50 breast cancer patients. We sought to repeat this study in a larger cohort of 120 patients.",
author = "Kerry Dunn and Andrew Hindley and Lisa Wood and Alison Sanneh and David Barber and Anne Whitehead and Zakiyah Zain",
year = "2013",
month = oct,
doi = "10.1016/j.ijrobp.2013.06.297",
language = "English",
volume = "87",
pages = "S115",
journal = "International Journal of Radiation Oncology - Biology - Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2 Supplement",
note = "American Society for Radiation Oncology ; Conference date: 22-09-2013 Through 25-09-2013",
}
RIS
TY - JOUR
T1 - Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy
T2 - American Society for Radiation Oncology
AU - Dunn, Kerry
AU - Hindley, Andrew
AU - Wood, Lisa
AU - Sanneh, Alison
AU - Barber, David
AU - Whitehead, Anne
AU - Zain, Zakiyah
PY - 2013/10
Y1 - 2013/10
N2 - The most common acute side effect of patients receiving radiation therapy to the breast/chest wall is radiation induced dermatitis. Despite this, there is no accepted intervention to prevent or treat it. A previous study by Bostrom et al showed Mometasone Furoate (M) cream was superior to Diprobase (D) in a study of 50 breast cancer patients. We sought to repeat this study in a larger cohort of 120 patients.
AB - The most common acute side effect of patients receiving radiation therapy to the breast/chest wall is radiation induced dermatitis. Despite this, there is no accepted intervention to prevent or treat it. A previous study by Bostrom et al showed Mometasone Furoate (M) cream was superior to Diprobase (D) in a study of 50 breast cancer patients. We sought to repeat this study in a larger cohort of 120 patients.
U2 - 10.1016/j.ijrobp.2013.06.297
DO - 10.1016/j.ijrobp.2013.06.297
M3 - Meeting abstract
VL - 87
SP - S115
JO - International Journal of Radiation Oncology - Biology - Physics
JF - International Journal of Radiation Oncology - Biology - Physics
SN - 0360-3016
IS - 2 Supplement
Y2 - 22 September 2013 through 25 September 2013
ER -